AI assistant
Entera Bio Ltd. — Director's Dealing 2024
Jun 7, 2024
35604_dirs_2024-06-07_29c31223-2bb4-4dc8-a5f8-3d5ab103df0a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-05-28
Reporting Person: Burshtein Gregory (Chief of R&D)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | 75126 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.97 | 2029-01-17 | Ordinary Shares, par value NIS 0.0000769 per share (20000) | Direct | |
| Stock Option (right to buy) | $2.14 | 2030-03-16 | Ordinary Shares, par value NIS 0.0000769 per share (18900) | Direct | |
| Stock Option (right to buy) | $3.61 | 2031-04-07 | Ordinary Shares, par value NIS 0.0000769 per share (51000) | Direct | |
| Stock Option (right to buy) | $2.57 | 2032-04-28 | Ordinary Shares, par value NIS 0.0000769 per share (45000) | Direct | |
| Stock Option (right to buy) | $0.795 | 2033-03-24 | Ordinary Shares, par value NIS 0.0000769 per share (65000) | Direct | |
| Stock Option (right to buy) | $1.99 | 2034-04-19 | Ordinary Shares, par value NIS 0.0000769 per share (150000) | Direct |
Footnotes
F1: Includes a grant of 25,126 stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
F2: The options vest over a four-year period that commenced on January 17, 2019, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F3: The options vest over a four-year period that commenced on March 16, 2020, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F4: The options vest over a four-year period that commenced on April 7, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F5: The options vest over a four-year period that commenced on April 28, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F6: The options vest over a four-year period that commenced on April 24, 2023, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F7: The options vest over a three-year period that commenced on April 19, 2024, with 33% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.